Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Natalia M. Flores, Javier Nuevo, Alyssa B. Klein, Scott Baumgartner & Robert Morlock. (2019) The economic burden of uncontrolled gout: how controlling gout reduces cost. Journal of Medical Economics 22:1, pages 1-6.
Read now
Read now
Yi-Yun Lee, Chao-Hsiun Tang, Jin-Hua Chen, Li-Na Kuo & Yu Ko. (2018) Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study. Current Medical Research and Opinion 34:4, pages 735-740.
Read now
Read now
F. Perez-Ruiz, C. Díaz-Torné & D. Carcedo. (2016) Cost-effectiveness analysis of febuxostat in patients with gout in Spain. Journal of Medical Economics 19:6, pages 604-610.
Read now
Read now
Seonghae Yoon, Donghoon Shin, Howard Lee, In-Jin Jang & Kyung-Sang Yu. (2015) Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects. Drug Design, Development and Therapy 9, pages 5033-5049.
Read now
Read now
Albert I. Wertheimer, Matthew W. Davis & Thomas J. Lauterio. (2011) A new perspective on the pharmacoeconomics of colchicine. Current Medical Research and Opinion 27:5, pages 931-937.
Read now
Read now
N.L. Edwards, J.S. Sundy, A. Forsythe, S. Blume, F. Pan & M.A. Becker. (2011) Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. Journal of Medical Economics 14:1, pages 10-15.
Read now
Read now
Richard A. Brook, Anna Forsythe, James E. Smeeding & N. Lawrence Edwards. (2010) Chronic gout: epidemiology, disease progression, treatment and disease burden. Current Medical Research and Opinion 26:12, pages 2813-2821.
Read now
Read now
Rachel Halpern, Reema R. Mody, Mahesh J. Fuldeore, Pankaj A. Patel & Ted R. Mikuls. (2009) Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Current Medical Research and Opinion 25:7, pages 1711-1719.
Read now
Read now
Richard A. Brook, Krithika Rajagopalan, Nathan L. Kleinman & Arthur K. Melkonian. (2009) Absenteeism and health-benefit costs among employees with MS. Current Medical Research and Opinion 25:6, pages 1469-1476.
Read now
Read now
Articles from other publishers (48)
Zachary Bowen‐Davies, Sara Muller, Christian D. Mallen, Richard A. Hayward & Edward Roddy. (2018) Gout Severity, Socioeconomic Status, and Work Absence: A Cross‐Sectional Study in Primary Care. Arthritis Care & Research 70:12, pages 1822-1828.
Crossref
Crossref
Valgerdur Sigurdardottir, Panagiota Drivelegka, Anna Svärd, Lennart T H Jacobsson & Mats Dehlin. (2018) Work disability in gout: a population-based case–control study. Annals of the Rheumatic Diseases 77:3, pages 399-404.
Crossref
Crossref
Aren Fischer, Michel Cloutier, Jason Goodfield, Richard Borrelli, Dawn Marvin & Alison Dziarmaga. (2017) The Direct Economic Burden of Gout in an Elderly Canadian Population. The Journal of Rheumatology 44:1, pages 95-101.
Crossref
Crossref
Ghaith Mitri, Eric T. Wittbrodt, Robin S. Turpin, Beni A. Tidwell & Kathy L. Schulman. (2016) Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease. Journal of Managed Care & Specialty Pharmacy 22:4, pages 326-336.
Crossref
Crossref
Zhao-Wei Zhou, Ling-Ling Cui, Lin Han, Can Wang, Zhi-Jian Song, Jia-Wei Shen, Zhi-Qiang Li, Jian-Hua Chen, Zu-Jia Wen, Xiao-Min Wang, Yong-Yong Shi & Chang-Gui Li. (2015) Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case–control study. BMC Medical Genetics 16:1.
Crossref
Crossref
Martijn A.H. Oude Voshaar, Thomas Bardin & Martinus A.F.J. van de Laar. (2015) The Human and Economic Burden of Difficult-to-Treat Gouty Arthritis. Joint Bone Spine 82, pages eS2-eS8.
Crossref
Crossref
Gemma E. Shields & Stephen M. Beard. (2015) A Systematic Review of the Economic and Humanistic Burden of Gout. PharmacoEconomics 33:10, pages 1029-1047.
Crossref
Crossref
Sharan K. Rai, Lindsay C. Burns, Mary A. De Vera, Aliya Haji, Dean Giustini & Hyon K. Choi. (2015) The economic burden of gout: A systematic review. Seminars in Arthritis and Rheumatism 45:1, pages 75-80.
Crossref
Crossref
Robert Jackson, Aki Shiozawa, Erin K Buysman, Aylin Altan, Stephanie Korrer & Hyon Choi. (2015) Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis. BMJ Open 5:6, pages e007214.
Crossref
Crossref
Natalie Tanner, Ross Diaper, Mathew King & Stuart A. Metcalfe. (2015) Case study: A case of debilitating gout in the 1st metatarsophalangeal joint. The Foot 25:1, pages 45-50.
Crossref
Crossref
Bart Spaetgens, José M.A. Wijnands, Caroline van Durme, Sjef van der Linden & Annelies Boonen. (2015) Cost of Illness and Determinants of Costs Among Patients with Gout. The Journal of Rheumatology 42:2, pages 335-344.
Crossref
Crossref
Mark C. Fisher, Michael H. Pillinger & Robert T. Keenan. (2014) Inpatient Gout: A Review. Current Rheumatology Reports 16:11.
Crossref
Crossref
Priya Varghese Chowalloor, Teck K. Siew & Helen Isobel Keen. (2014) Imaging in gout: A review of the recent developments. Therapeutic Advances in Musculoskeletal Disease 6:4, pages 131-143.
Crossref
Crossref
Nathan KleinmanAarti A. PatelCarmela BensonAlex MacarioMyoung KimDavid M. Biondi. (2014) Economic Burden of Back and Neck Pain: Effect of a Neuropathic Component. Population Health Management 17:4, pages 224-232.
Crossref
Crossref
B. Spaetgens, S. van der Linden & A. Boonen. (2013) The Gout Assessment Questionnaire 2.0: cross-cultural translation into Dutch, aspects of validity and linking to the International Classification of Functioning, Disability and Health. Rheumatology 53:4, pages 678-685.
Crossref
Crossref
Albert Wertheimer, Robert Morlock & Michael A. Becker. (2013) A Revised Estimate of the Burden of Illness of Gout. Current Therapeutic Research 75, pages 1-4.
Crossref
Crossref
Stephen M. Beard, Birgitta G. von Scheele, George Nuki & Isobel V. Pearson. (2013) Cost-effectiveness of febuxostat in chronic gout. The European Journal of Health Economics.
Crossref
Crossref
Wendy LynchWing ChanNathan KleinmanL.M. AndrewsAnthony M. Yadao. (2013) Economic Burden of Gouty Arthritis Attacks for Employees with Frequent and Infrequent Attacks. Population Health Management 16:2, pages 138-145.
Crossref
Crossref
Nathan L. Kleinman, Mary A. Cifaldi, James E. Smeeding, James W. Shaw & Richard A. Brook. (2013) Annual Incremental Health Benefit Costs and Absenteeism Among Employees With and Without Rheumatoid Arthritis. Journal of Occupational & Environmental Medicine 55:3, pages 240-244.
Crossref
Crossref
Antoni Sicras-Mainar, Ruth Navarro-Artieda & Jordi Ibáñez-Nolla. (2013) Resource Use and Economic Impact of Patients With Gout: A Multicenter, Population-Wide Study. Reumatología Clínica (English Edition) 9:2, pages 94-100.
Crossref
Crossref
Antoni Sicras-Mainar, Ruth Navarro-Artieda & Jordi Ibáñez-Nolla. (2013) Uso de recursos e impacto económico de los pacientes con gota: estudio multicéntrico de ámbito poblacional. Reumatología Clínica 9:2, pages 94-100.
Crossref
Crossref
J. Zeidler, A. Lange, S. Braun, R. Linder, S. Engel, F. Verheyen & J.-M. Graf von der Schulenburg. (2013) Die Berechnung indikationsspezifischer Kosten bei GKV-Routinedatenanalysen am Beispiel von ADHSCalculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:3, pages 430-438.
Crossref
Crossref
Anna Köttgen, Eva Albrecht, Alexander Teumer, Veronique Vitart, Jan Krumsiek, Claudia Hundertmark, Giorgio Pistis, Daniela Ruggiero, Conall M O'Seaghdha, Toomas Haller, Qiong Yang, Toshiko Tanaka, Andrew D Johnson, Zoltán Kutalik, Albert V Smith, Julia Shi, Maksim Struchalin, Rita P S Middelberg, Morris J Brown, Angelo L Gaffo, Nicola Pirastu, Guo Li, Caroline Hayward, Tatijana Zemunik, Jennifer Huffman, Loic Yengo, Jing Hua Zhao, Ayse Demirkan, Mary F Feitosa, Xuan Liu, Giovanni Malerba, Lorna M Lopez, Pim van der Harst, Xinzhong Li, Marcus E Kleber, Andrew A Hicks, Ilja M Nolte, Asa Johansson, Federico Murgia, Sarah H Wild, Stephan J L Bakker, John F Peden, Abbas Dehghan, Maristella Steri, Albert Tenesa, Vasiliki Lagou, Perttu Salo, Massimo Mangino, Lynda M Rose, Terho Lehtimäki, Owen M Woodward, Yukinori Okada, Adrienne Tin, Christian Müller, Christopher Oldmeadow, Margus Putku, Darina Czamara, Peter Kraft, Laura Frogheri, Gian Andri Thun, Anne Grotevendt, Gauti Kjartan Gislason, Tamara B Harris, Lenore J Launer, Patrick McArdle, Alan R Shuldiner, Eric Boerwinkle, Josef Coresh, Helena Schmidt, Michael Schallert, Nicholas G Martin, Grant W Montgomery, Michiaki Kubo, Yusuke Nakamura, Toshihiro Tanaka, Patricia B Munroe, Nilesh J Samani, David R JacobsJrJr, Kiang Liu, Pio D'Adamo, Sheila Ulivi, Jerome I Rotter, Bruce M Psaty, Peter Vollenweider, Gerard Waeber, Susan Campbell, Olivier Devuyst, Pau Navarro, Ivana Kolcic, Nicholas Hastie, Beverley Balkau, Philippe Froguel, Tõnu Esko, Andres Salumets, Kay Tee Khaw, Claudia Langenberg, Nicholas J Wareham, Aaron Isaacs, Aldi Kraja, Qunyuan Zhang, Philipp S Wild, Rodney J Scott, Elizabeth G Holliday, Elin Org, Margus Viigimaa, Stefania Bandinelli, Jeffrey E Metter, Antonio Lupo, Elisabetta Trabetti, Rossella Sorice, Angela Döring, Eva Lattka, Konstantin Strauch, Fabian Theis, Melanie Waldenberger, H-Erich Wichmann, Gail Davies, Alan J Gow, Marcel Bruinenberg, Ronald P Stolk, Jaspal S Kooner, Weihua Zhang, Bernhard R Winkelmann, Bernhard O Boehm, Susanne Lucae, Brenda W Penninx, Johannes H Smit, Gary Curhan, Poorva Mudgal, Robert M Plenge, Laura Portas, Ivana Persico, Mirna Kirin, James F Wilson, Irene Mateo Leach, Wiek H van Gilst, Anuj Goel, Halit Ongen, Albert Hofman, Fernando Rivadeneira, Andre G Uitterlinden, Medea Imboden, Arnold von Eckardstein, Francesco Cucca, Ramaiah Nagaraja, Maria Grazia Piras, Matthias Nauck, Claudia Schurmann, Kathrin Budde, Florian Ernst, Susan M Farrington, Evropi Theodoratou, Inga Prokopenko, Michael Stumvoll, Antti Jula, Markus Perola, Veikko Salomaa, So-Youn Shin, Tim D Spector, Cinzia Sala, Paul M Ridker, Mika Kähönen, Jorma Viikari, Christian Hengstenberg, Christopher P Nelson, James F Meschia, Michael A Nalls, Pankaj Sharma, Andrew B Singleton, Naoyuki Kamatani, Tanja Zeller, Michel Burnier, John Attia, Maris Laan, Norman Klopp, Hans L Hillege, Stefan Kloiber, Hyon Choi, Mario Pirastu, Silvia Tore, Nicole M Probst-Hensch, Henry Völzke, Vilmundur Gudnason, Afshin Parsa, Reinhold Schmidt, John B Whitfield, Myriam Fornage, Paolo Gasparini, David S Siscovick, Ozren Polašek, Harry Campbell, Igor Rudan, Nabila Bouatia-Naji, Andres Metspalu, Ruth J F Loos, Cornelia M van Duijn, Ingrid B Borecki, Luigi Ferrucci, Giovanni Gambaro, Ian J Deary, Bruce H R Wolffenbuttel, John C Chambers, Winfried März, Peter P Pramstaller, Harold Snieder, Ulf Gyllensten, Alan F Wright, Gerjan Navis, Hugh Watkins, Jacqueline C M Witteman, Serena Sanna, Sabine Schipf, Malcolm G Dunlop, Anke Tönjes, Samuli Ripatti, Nicole Soranzo, Daniela Toniolo, Daniel I Chasman, Olli Raitakari, W H Linda Kao, Marina Ciullo, Caroline S Fox, Mark Caulfield, Murielle Bochud & Christian Gieger. (2012) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nature Genetics 45:2, pages 145-154.
Crossref
Crossref
Carlo Scirè, Maria Manara, Marco Cimmino, Marcello Govoni, Fausto Salaffi, Leonardo Punzi, Maria Monti, Greta Carrara, Carlomaurizio Montecucco, Marco Matucci-Cerinic & Giovanni Minisola. (2013) Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Research & Therapy 15:5, pages R101.
Crossref
Crossref
Puja P Khanna, George Nuki, Thomas Bardin, Anne-Kathrin Tausche, Anna Forsythe, Amir Goren, Jeffrey Vietri & Dinesh Khanna. (2012) Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health and Quality of Life Outcomes 10:1.
Crossref
Crossref
William J. Taylor, Meaghan House, Anne Horne, Fiona M. McQueen & Nicola Dalbeth. (2012) The Work Instability Scale Predicts Absenteeism in People With Gout and Suggests a Higher Risk for Those in Manual Occupations. Journal of Clinical Rheumatology 18:8, pages 405-410.
Crossref
Crossref
Eric Q. Wu, Anna Forsythe, Annie Guérin, Andrew P. Yu, Dominick Latremouille-Viau & Magda Tsaneva. (2012) Comorbidity Burden, Healthcare Resource Utilization, and Costs in Chronic Gout Patients Refractory to Conventional Urate-Lowering Therapy. American Journal of Therapeutics 19:6, pages e157-e166.
Crossref
Crossref
Joseph J. Saseen, Neetu Agashivala, Richard Read Allen, Vahram Ghushchyan, Anthony M. Yadao & Kavita V. Nair. (2012) Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology 51:11, pages 2004-2012.
Crossref
Crossref
Dinesh Khanna, Puja P. Khanna, John D. Fitzgerald, Manjit K. Singh, Sangmee Bae, Tuhina Neogi, Michael H. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez‐Ruiz, Will Taylor, Frédéric Lioté, Hyon Choi, Jasvinder A. Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A. Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E. Furst, N. Lawrence Edwards, Brian Mandell, H. Ralph Schumacher, Mark Robbins, Neil Wenger & Robert Terkeltaub. (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care & Research 64:10, pages 1447-1461.
Crossref
Crossref
Haesuk Park, Karen L. Rascati, Karim Prasla & Tyrone McBayne. (2012) Evaluation of Health Care Costs and Utilization Patterns for Patients With Gout. Clinical Therapeutics 34:3, pages 640-652.
Crossref
Crossref
Jasvinder A. Singh. 2011. Evidence‐Based Orthopedics. Evidence‐Based Orthopedics
86
92
.
Naomi Schlesinger. (2011) Difficult-to-Treat Gouty Arthritis. Drugs 71:11, pages 1413-1439.
Crossref
Crossref
Jasvinder A. Singh, A. Sarkin, M. Shieh, D. Khanna, R. Terkeltaub, S.J. Lee, A. Kavanaugh & J.D. Hirsch. (2011) Health Care Utilization in Patients with Gout. Seminars in Arthritis and Rheumatism 40:6, pages 501-511.
Crossref
Crossref
S Kumar & Rajiva Gupta. 2011. Arthritis. Arthritis
3
21
.
Naomi Schlesinger, Marc De Meulemeester, Andrey Pikhlak, A Eftal Yücel, Dominik Richard, Valda Murphy, Udayasankar Arulmani, Peter Sallstig & Alexander So. (2011) Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study. Arthritis Research & Therapy 13:2.
Crossref
Crossref
Savvas Nicolaou, Steven John Co & Daniel James Hou. 2011. Dual Energy CT in Clinical Practice. Dual Energy CT in Clinical Practice
199
213
.
Nicholas J. Rohrbacker, Nathan L. Kleinman, Sarah A. White, Jamie L. March & Matthew R. Reynolds. (2010) The Burden of Atrial Fibrillation and Other Cardiac Arrhythmias in an Employed Population: Associated Costs, Absences, and Objective Productivity Loss. Journal of Occupational & Environmental Medicine 52:4, pages 383-391.
Crossref
Crossref
Nathan L. Kleinman, Richard A. Brook & Sulabha Ramachandran. (2009) An employer perspective on annual employee and dependent costs for pediatric asthma. Annals of Allergy, Asthma & Immunology 103:2, pages 114-120.
Crossref
Crossref
SEO YOUNG KIM & HYON K. CHOI. (2009) Gout and Quality of Life: Table 1.. The Journal of Rheumatology 36:5, pages 865-868.
Crossref
Crossref
Nathan L. Kleinman, Arthur Melkonian, Spencer Borden, Nicholas Rohrbacker, Wendy D. Lynch & Harold H. Gardner. (2009) The Impact of Morbid Obesity and Bariatric Surgery on Comorbid Conditions: A Comprehensive Examination of Comorbidities in an Employed Population. Journal of Occupational & Environmental Medicine 51:2, pages 170-179.
Crossref
Crossref
Jasvinder A. Singh. (2009) Health Care Costs in Gout. JCR: Journal of Clinical Rheumatology 15:1, pages 1-2.
Crossref
Crossref
Gunilla Norrmén, Kurt Svärdsudd & Dan KG Andersson. (2008) How primary health care physicians make sick listing decisions: The impact of medical factors and functioning. BMC Family Practice 9:1.
Crossref
Crossref
Dinesh Khanna, Mansoor Ahmed, Dustin Yontz, Shaari S. Ginsburg & Joel Tsevat. (2008) Willingness to Pay for a Cure in Patients with Chronic Gout. Medical Decision Making 28:4, pages 606-613.
Crossref
Crossref
Hein JEM Janssens, Matthijs Janssen, Eloy H van de Lisdonk, Piet LCM van Riel & Chris van Weel. (2008) Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. The Lancet 371:9627, pages 1854-1860.
Crossref
Crossref
R. A. BROOK, P. WAHLQVIST, N. L. KLEINMAN, M.-A. WALLANDER, S. M. CAMPBELL & J. E. SMEEDING. (2007) Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Alimentary Pharmacology & Therapeutics 26:6, pages 889-898.
Crossref
Crossref
Michael H. Alderman. (2007) Podagra, Uric Acid, and Cardiovascular Disease. Circulation 116:8, pages 880-883.
Crossref
Crossref
Arthur Kavanaugh. (2007) Economic issues with new rheumatologic therapeutics. Current Opinion in Rheumatology 19:3, pages 272-276.
Crossref
Crossref
. (2013) Gout a painful burden for employers. PharmacoEconomics & Outcomes News 511:1, pages 5-5.
Crossref
Crossref